XML 29 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Intangible Assets - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
6 Months Ended 6 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Jun. 30, 2013
Minimum [Member]
Jun. 30, 2013
Maximum [Member]
Jun. 30, 2013
Western European [Member]
Operations
Jun. 30, 2013
Third Party [Member]
Jun. 30, 2013
MEAAP [Member]
Jun. 30, 2013
Uteron Pharma, SA [Member]
Jan. 23, 2013
Uteron Pharma, SA [Member]
Jun. 30, 2013
Medicines360 [Member]
Finite-Lived Intangible Assets [Line Items]                    
Goodwill $ 4,192.5 $ 4,854.2       $ 125.0 $ 178.0      
Increase in the discount rate, basis point 100.00%                  
Increase in fair value of goodwill     6.00% 23.00%            
Number of commercial operations                     
Discounted cash flow years 5 years                  
Residual growth rate     2.00% 4.00%            
Discount rate 8.00%                  
Goodwill impairment 647.5                  
Acquisition of intangible assets relating to IPR&D               250.0 250.0 190.4
IPR&D intangibles transferred to product rights and other related intangibles 185.3                  
IPR&D impairment $ 4.4